A systematic review and economic model of the effectiveness and cost-effectiveness of methylphenidate, dexamfetamine and atomoxetine for the treatment of attention deficit hyperactivity disorder in children and adolescents.

Source:http://linkedlifedata.com/resource/pubmed/id/16796929

Download in:

View as

General Info

PMID
16796929